%0 Journal Article
%T Epidemiology of Travel-Associated Dengue from 2007 to 2022: A GeoSentinel Analysis.
%A Duvignaud A
%A Stoney RJ
%A Angelo D O KM
%A Chen LH
%A Cattaneo P
%A Motta L
%A Gobbi FG
%A Bottieau E
%A Bourque DL
%A Popescu CP
%A Glans H
%A Asgeirsson H
%A Oliveira-Souto I
%A Vaughan SD
%A Amatya B
%A Norman FF
%A Waggoner J
%A Diaz-Menendez M
%A Beadsworth M
%A Odolini S
%A Camprubí-Ferrer D
%A Epelboin L
%A Connor BA
%A Eperon G
%A Schwartz E
%A Libman M
%A Malvy D
%A Hamer DH
%A Huits R
%A  
%J J Travel Med
%V 0
%N 0
%D 2024 Jul 2
%M 38951998
%F 39.194
%R 10.1093/jtm/taae089
%X <B>BACKGROUND: </B>Dengue is a leading cause of febrile illness among international travellers. We aimed to describe the epidemiology and clinical characteristics of imported dengue in returning travellers evaluated at GeoSentinel sites from 2007-2022.<BR><B>METHODS: </B>We retrieved GeoSentinel records of dengue among travellers residing in non-endemic countries. We considered dengue confirmed when diagnosed by a positive DENV-specific RT-PCR, positive NS-1 antigen, and/or anti-DENV IgG seroconversion, and probable when diagnosed by single anti-DENV IgM or high titre anti-DENV IgG detection. Severe dengue was defined as evidence of clinically significant plasma leakage or bleeding, organ failure, or shock, according to the 2009 WHO guidance. Complicated dengue was defined as either severe dengue or dengue with presence of any warning sign. Analyses were descriptive.<BR><B>RESULTS: </B>This analysis included 5958 travellers with confirmed (n = 4859; 81.6%) or probable (n = 1099; 18.4%) dengue. The median age was 33 years (range: < 1-91); 3007 (50.5%) travellers were female. The median travel duration was 21 days (interquartile range [IQR]: 15-32). The median time between illness onset and GeoSentinel site visit was 7 days (IQR: 4-15). The most frequent reasons for travel were tourism (67.3%), visiting friends or relatives (12.2%), and business (11.0%). The most frequent regions of acquisition were Southeast Asia (50.4%), South-Central Asia (14.9%), the Caribbean (10.9%), and South America (9.2%). Ninety-five (1.6%) travellers had complicated dengue, of whom 27 (0.5%) had severe dengue, and one died. Of 2710 travellers with data available, 724 (26.7%) were hospitalized. The largest number of cases (n = 835) was reported in 2019.<BR><B>CONCLUSIONS: </B>A broad range of international travellers should be aware of the risk of acquiring dengue and receive appropriate pretravel counselling regarding preventive measures. Prospective cohort studies are needed to further elucidate dengue risk by destination and over time, as well as severe outcomes and prolonged morbidity (long-dengue) due to travel-related dengue.